ABSTRACT
Background Urinary tract infections (UTI) contribute to substantive proportions of adverse pregnancy outcomes. Current national statistics in Kenya show high maternal mortality (488/100,000) and neonatal mortality (24/1,000) rates. Kenya continues to report increasing prevalence and incidence rates of UTI associated with maternal and neonatal deaths. Kisumu County in western Kenya has a high maternal mortality rate of 495/100,000 with uncaptured maternal morbidity relative to the national average. However, information on the epidemiology of gestational UTI in the County, is limited. Semi-urban Chulaimbo and Nyahera Sub-County hospitals were used as model facilities to establish the burden of UTI during pregnancy and the specific clinical diagnosis and therapeutic management strategies.
Methods Socio-demographic, laboratory and clinical history data was extracted from 416 pregnant women’s maternal child health data sets from health records between February 2019 to February 2020 using pre-designed data collection forms. Descriptive analysis was used to summarize the study population’s demographic characteristics. Chi-square test was used to establish proportionality. Qualitative data were thematically summarized. For all analyses, P≤0.05 was considered statistically significant.
Results The study population had a mean of two (2) (±1.14) ante-natal (ANC) visits; a mean mothers age of 23.92 (± 6) years old; a mean parity of 2 (±2) and a mean haemoglobin level of 10.73(±1.8). About 56% (233/416) of the mothers attended the first ANC visit at varied gestational age. Only 1.4% (6/416) had a clinical history capturing UTI infection out of the total prevalence of 57.9% (241/416) diagnosed UTI positive by routine ANC profile deep stick urinalysis test. These clinical history data sets 1.4% (6/416) revealed a broad-spectrum therapeutic management of gestational bacterial infections using first line antibiotics.
Conclusions Most UTI positive cases go without specific clinical diagnosis and management, posing a high risk of antibiotic drug resistance and development of specific bacterial allied gestational complications.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
None
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Maseno University Ethics and Review Committee
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Footnotes
E-mail addresses of authors: ENT (E-mail: eunicetoko{at}gmail.com); SS (E-mail: ssamarasinghe{at}dmu.ac.uk); EF (E-mail: estherfurabahekwa{at}gmail.com); TK (E-mail: tariq.kapasi{at}nhs.net); BO (E-mail: bertha.ochieng{at}dmu.ac.uk).
Data Availability
Data will be available from the corresponding author upon request.
LIST OF ABBREVIATIONS
- AMPATH
- Academic Model Providing Access to Healthcare
- ANC
- Antenatal Care
- ASB
- Asymptomatic Bacteriuria
- AST
- Antibiotic Susceptibility Test
- CMR
- Child Mortality Rate
- GCRF
- Global Challenge Research Fund
- IMR
- Infant Mortality Rate
- IPTp
- Intermittent Preventive Treatment of Malaria in Pregnancy
- KII
- Key Informant Interviews
- LMIC
- Low-and Middle-Income Countries
- MCH
- Maternal Child Health
- MDR
- Multidrug Resistance
- MMR
- Maternal Mortality Rate
- MOH
- Ministry of Health
- NMR
- Neonatal Mortality Rate
- MUERC
- Maseno University Ethical Review Committee
- UTI
- Urinary Tract Infections
- WHO
- World Health Organization
